BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15967043)

  • 21. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
    Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
    Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
    Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
    Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Podoplanin and E-cadherin expression in preoperative incisional biopsies of oral squamous cell carcinoma is related to lymph node metastases.
    Foschini MP; Leonardi E; Eusebi LH; Farnedi A; Poli T; Tarsitano A; Cocchi R; Marchetti C; Gentile L; Sesenna E; Marucci G; Montebugnoli L
    Int J Surg Pathol; 2013 Apr; 21(2):133-41. PubMed ID: 23349470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
    Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J
    J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of N-Cadherin expression in oral squamous cell carcinoma.
    DI Domenico M; Pierantoni GM; Feola A; Esposito F; Laino L; DE Rosa A; Rullo R; Mazzotta M; Martano M; Sanguedolce F; Perillo L; D'Angelo L; Papagerakis S; Tortorella S; Bufo P; Lo Muzio L; Pannone G; Santoro A
    Anticancer Res; 2011 Dec; 31(12):4211-8. PubMed ID: 22199283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Tsai TC; Yu CH; Cheng SJ; Liu BY; Chen HM; Chiang CP
    Oral Oncol; 2008 Aug; 44(8):759-66. PubMed ID: 18061525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma.
    Moergel M; Abt E; Stockinger M; Kunkel M
    Oral Oncol; 2010 Sep; 46(9):667-71. PubMed ID: 20656547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
    Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
    J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
    Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
    J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
    Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
    Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent prognostic factors of 861 cases of oral squamous cell carcinoma in Korean adults.
    Choi KK; Kim MJ; Yun PY; Lee JH; Moon HS; Lee TR; Myoung H
    Oral Oncol; 2006 Feb; 42(2):208-17. PubMed ID: 16249114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of E-cadherin and matrix metalloproteinase-9 in oral squamous cell carcinoma and histologically negative surgical margins and association with clinicopathological parameters.
    Mohtasham N; Anvari K; Memar B; Saghravanian N; Ghazi N; Bagherpour A; Ramtin M
    Rom J Morphol Embryol; 2014; 55(1):117-21. PubMed ID: 24715175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma.
    Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
    Oral Oncol; 2006 Feb; 42(2):190-200. PubMed ID: 16249116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of carcinoembryonic antigen-related cell adhesion molecule 1 in oral squamous cell carcinoma: correlation with tumor progression and poor prognosis.
    Shinozuka K; Uzawa K; Fushimi K; Yamano Y; Shiiba M; Bukawa H; Yokoe H; Tanzawa H
    Oncology; 2009; 76(6):387-97. PubMed ID: 19407471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
    Hamada T; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
    Cancer; 2012 Nov; 118(21):5251-64. PubMed ID: 22434549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
    Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
    Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma.
    Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
    Oral Dis; 2007 May; 13(3):285-90. PubMed ID: 17448210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.